Last reviewed · How we verify
NCT06915103
A Case Report of NMDAR Encephalopathy
trial testing Magnetic Resonance Imaging (MRI) in Anti-NMDA Receptor Encephalitis in 1 participant. Completed in 19 December 2024.
8 July 2024
Quick facts
| Lead sponsor | Mayo Clinic |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 1 |
| Start date | 20 June 2024 |
| Primary completion | 8 July 2024 |
| Estimated completion | 19 December 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Magnetic Resonance Imaging (MRI)
- Salpingo-oophorectomy
Conditions studied
- Anti-NMDA Receptor Encephalitis — all drugs for Anti-NMDA Receptor Encephalitis →
- Mature Teratoma — all drugs for Mature Teratoma →
- Paraneoplastic Syndromes — all drugs for Paraneoplastic Syndromes →
Sponsor
Mayo Clinic
Who can join
Adults 34 to 34, female only, with Anti-NMDA Receptor Encephalitis or Mature Teratoma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This case illustrates the clinical, radiologic, and histopathologic features of Anti-NMDAR encephalitis and underscores the importance of MRI in detecting ovarian teratomas when pelvic ultrasound is inconclusive.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
A case report of NMDAR encephalopathy - A neurologic condition that a gynecologist can cure.
Molina MP, Drake E, El-Nashar S, Desai MA, et al · · 2025 · PMID 40273580 · DOI 10.1016/j.ijscr.2025.111219
Verify or expand the search:
- PubMed search for NCT06915103
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Magnetic Resonance Imaging (MRI)
Trials testing the same drug.
- NCT07226453 — Target Validation and Efficacy of Metformin in Patients With Posterior Fossa Group A (PFA) Ependymoma · Phase 2 · not yet recruiting
- NCT07346170 — Short Interval Postoperative Stereotactic Body Radiation Therapy (SBRT) After Surgical Intervention for Spine Metastases · NA · not yet recruiting
- NCT07110246 — Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade Gliomas · Phase 2 · recruiting
- NCT07185958 — Dual Energy CT - a Tool for Delineation of Tumor and Organs at Risk in Radiotherapy · not yet recruiting
- NCT06492057 — Electromyostimulation (EMS) of Astronauts in Spaceflight (Easymotion-2) · NA · enrolling by invitation
Other recruiting trials for Anti-NMDA Receptor Encephalitis
Currently open trials in the same condition.
- NCT06183788 — Antibody-mediated NMDA Receptor Encephalitis: Symptoms, Biomarkers, and Mechanisms of the Prolonged Recovery Stage · NA · recruiting
Other Mayo Clinic trials
Trials by the same sponsor.
- NCT07126548 — A Point of Prostate Cancer Diagnosis Virtual Reality Assistant Intervention in Supporting Newly Diagnosed Black Men · NA · not yet recruiting
- NCT07221656 — Evaluation of Prolonged Asparaginase Activity Levels After Calaspargase Pegol Administration · not yet recruiting
- NCT06891001 — The Utilization of a Shoe Insert on Individuals With Unilateral Greater Trochanteric Pain Syndrome on Single Leg Stance, · NA · not yet recruiting
- NCT07169799 — Impact of Cryotherapy Spray (Tru-Freeze) for the Eradication of Gastric Antral Vascular Ectasia (ICE-GAVE) · NA · recruiting
- NCT07086183 — Perioperative Risk in Patients on Chronic Aspirin Undergoing Craniotomy · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06915103 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mayo Clinic
- Last refreshed: 8 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06915103.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing